NCT05255588
A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer No drug interventions Not Available Not Available recruiting NCT01341197
Fecal Screening Assay for Taiwanese Population No drug interventions Not Available Not Available completed NCT01929421
A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer. treatment 2 completed NCT00853684
Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer treatment 2 unknown_status NCT05963087
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer treatment Not Available not_yet_recruiting NCT05028933
IMC001 for Clinical Research on Advanced Digestive System Malignancies No drug interventions treatment 1 recruiting NCT00598247
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer treatment 1 completed NCT00386828
Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial treatment 2 completed NCT03699111
Identification of New Patient Stratification Tools in MSS RAS mt mCRC No drug interventions Not Available Not Available completed NCT06585488
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants with Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplification No drug interventions treatment 1 not_yet_recruiting NCT00498407
A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer treatment 2 completed NCT02826837
LEAC-102 for Advanced Colorectal Cancer treatment 1 / 2 unknown_status NCT00286000
High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study treatment 2 completed NCT06369259
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer treatment 2 not_yet_recruiting NCT04793958
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) treatment 3 active_not_recruiting NCT05077839
Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC treatment 2 recruiting NCT02138422
A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer No drug interventions treatment 3 completed NCT06199973
Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan treatment 3 recruiting NCT00637091
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions treatment 2 completed NCT00707889
Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer treatment 2 completed NCT05364489
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer treatment 2 not_yet_recruiting NCT03427268
Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment treatment 2 completed NCT01723969
Screening Platform for Clinical Trials in Advanced Colorectal Cancer No drug interventions Not Available Not Available completed NCT06446050
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer No drug interventions treatment 0 recruiting NCT00309179
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors treatment 2 completed NCT04337879
A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer treatment 1 / 2 unknown_status NCT00824161
Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer treatment 2 terminated NCT03126071
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer treatment 2 unknown_status NCT00854971
Efficacy Study of TKcell in Advanced Colorectal Cancer treatment 1 / 2 unknown_status NCT04252456
Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status No drug interventions treatment Not Available unknown_status NCT04929652
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer treatment 1 / 2 unknown_status NCT00312000
Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma treatment 3 completed NCT02038699
A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer treatment 1 / 2 withdrawn NCT04764006
Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study treatment 2 unknown_status NCT04734249
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC treatment 2 unknown_status NCT05731336
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan. No drug interventions Not Available Not Available recruiting NCT04835324
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study No drug interventions Not Available Not Available unknown_status NCT00952016
Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency treatment 2 terminated NCT01859858
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors basic_science 1 completed NCT02619435
Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer treatment 2 active_not_recruiting NCT06200363
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer treatment 1 recruiting NCT02923622
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer No drug interventions Not Available Not Available unknown_status NCT01271166
Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer treatment 1 terminated NCT00972465
Study of Nimotuzumab to Treat Colorectal Cancer treatment 2 unknown_status NCT03524274
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer No drug interventions treatment 2 withdrawn NCT04744831
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer treatment 2 active_not_recruiting NCT04324476
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer treatment 2 unknown_status NCT01822444
ANGIOPREDICT. ICORG 12-16, V3 No drug interventions Not Available Not Available completed NCT02227667
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer treatment 2 completed NCT05495672
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules No drug interventions treatment Not Available recruiting NCT05424068
Rehabilitation for People With Advanced Cancer No drug interventions supportive_care Not Available recruiting NCT00959946
Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer treatment 1 / 2 terminated NCT05928312
Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer treatment Not Available not_yet_recruiting NCT05194995
JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation treatment 1 / 2 active_not_recruiting NCT05035914
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer treatment 1 / 2 recruiting NCT03311750
Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer treatment 2 terminated